Paper Details

  1. Home
  2. Paper Details

Effects of topical betaxolol in ocular hypertensive patients.

Author: CaldwellD R, GuzekJ P, SalisburyC R

Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Controlled Clinical TrialA clinical trial that evaluates the effectiveness of a treatment by comparing a group that receives the intervention with a group that receives a placebo or standard treatment.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Betaxolol, a beta 1-adrenergic blocker, effectively lowered intraocular pressure in patients with ocular hypertension without any observed side effects. It may be a useful alternative for patients who cannot tolerate timolol maleate.
Paper Details　
Original Abstract of the Article :
Betaxolol, a new beta 1-adrenergic blocker, was applied to 20 eyes of ten patients with ocular hypertension. Topical 0.25% betaxolol was found to significantly lower intraocular pressure compared with placebo. There were no subjective or objective ocular or systemic side effects detected. There were...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1001/archopht.1984.01040030417014

データ提供：米国国立医学図書館（NLM）

Topical Betaxolol: A Potential Treatment for Ocular Hypertension

In the realm of [ophthalmology], ocular hypertension poses a significant risk factor for developing glaucoma. This study investigates the efficacy of a new beta 1-adrenergic blocker, [betaxolol], in lowering intraocular pressure in patients with ocular hypertension. The researchers compared the effects of topical 0.25% betaxolol to placebo, evaluating changes in intraocular pressure and potential side effects. Their findings suggest that betaxolol may be a promising therapeutic option for managing ocular hypertension.

Topical Betaxolol Demonstrates Effectiveness in Lowering Intraocular Pressure

The study demonstrates that topical betaxolol effectively lowered intraocular pressure compared to placebo, suggesting its potential as a treatment for ocular hypertension. This finding holds promise for individuals seeking to manage this condition and prevent the development of glaucoma.

Navigating the Use of Betaxolol in Ocular Hypertension

While the study highlights the potential benefits of betaxolol, it's important to consider the potential for side effects and interactions with other medications. Further research is needed to fully understand the long-term safety and effectiveness of betaxolol in managing ocular hypertension.

Dr.Camel's Conclusion

Imagine a camel traversing a desert landscape, seeking a source of water. Just as the camel relies on its keen sense of smell to find water, researchers are seeking effective treatments for ocular hypertension. This study suggests that topical betaxolol holds promise as a potential treatment option, offering a potential oasis in the desert of eye health.
Date :
  1. Date Completed 1984-04-25
  2. Date Revised 2019-07-04
Further Info :

Pubmed ID

6704008

DOI: Digital Object Identifier

10.1001/archopht.1984.01040030417014

Related Literature

Article Analysis
・Side Effects of betaxolol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.